Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
5,010
JPY
|
+5.12%
|
|
+8.07%
|
+29.39%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,304,011
|
4,816,951
|
6,179,276
|
5,136,821
|
9,244,546
|
9,606,688
|
-
|
-
|
Enterprise Value (EV)
1 |
2,785,091
|
4,159,929
|
5,538,193
|
4,456,437
|
8,995,480
|
9,159,669
|
9,151,729
|
8,922,907
|
P/E ratio
|
35.4
x
|
37.3
x
|
82.3
x
|
76.7
x
|
84.7
x
|
45.6
x
|
50.1
x
|
35.1
x
|
Yield
|
1.37%
|
0.94%
|
0.84%
|
1.01%
|
0.62%
|
0.9%
|
1.13%
|
1.28%
|
Capitalization / Revenue
|
3.55
x
|
4.91
x
|
6.42
x
|
4.92
x
|
7.23
x
|
5.72
x
|
5.48
x
|
4.78
x
|
EV / Revenue
|
3
x
|
4.24
x
|
5.75
x
|
4.26
x
|
7.04
x
|
5.72
x
|
5.22
x
|
4.44
x
|
EV / EBITDA
|
21.4
x
|
21.7
x
|
45.7
x
|
33.9
x
|
47.8
x
|
36
x
|
31.9
x
|
22.6
x
|
EV / FCF
|
49.8
x
|
36.2
x
|
36.2
x
|
58.3
x
|
-62.8
x
|
130
x
|
84.2
x
|
61
x
|
FCF Yield
|
2.01%
|
2.76%
|
2.76%
|
1.72%
|
-1.59%
|
0.77%
|
1.19%
|
1.64%
|
Price to Book
|
2.64
x
|
3.69
x
|
4.86
x
|
3.8
x
|
6.39
x
|
5.43
x
|
5.97
x
|
5.5
x
|
Nbr of stocks (in thousands)
|
1,943,536
|
1,943,887
|
1,916,055
|
1,916,724
|
1,917,160
|
1,917,503
|
-
|
-
|
Reference price
2 |
1,700
|
2,478
|
3,225
|
2,680
|
4,822
|
5,010
|
5,010
|
5,010
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
929,717
|
981,793
|
962,516
|
1,044,900
|
1,278,478
|
1,601,700
|
1,752,938
|
2,008,390
|
EBITDA
1 |
129,874
|
191,411
|
121,177
|
131,270
|
188,369
|
251,664
|
286,771
|
394,488
|
EBIT
1 |
83,705
|
138,800
|
63,795
|
73,000
|
120,580
|
211,600
|
219,746
|
345,481
|
Operating Margin
|
9%
|
14.14%
|
6.63%
|
6.99%
|
9.43%
|
13.21%
|
12.54%
|
17.2%
|
Earnings before Tax (EBT)
1 |
85,831
|
141,164
|
74,124
|
73,500
|
126,854
|
237,200
|
224,447
|
366,374
|
Net income
1 |
93,409
|
129,074
|
75,958
|
67,000
|
109,188
|
200,700
|
185,183
|
273,574
|
Net margin
|
10.05%
|
13.15%
|
7.89%
|
6.41%
|
8.54%
|
12.53%
|
10.56%
|
13.62%
|
EPS
2 |
48.07
|
66.40
|
39.17
|
34.94
|
56.96
|
104.7
|
100.0
|
142.7
|
Free Cash Flow
1 |
55,925
|
114,928
|
152,961
|
76,490
|
-143,268
|
69,530
|
108,659
|
146,320
|
FCF margin
|
6.02%
|
11.71%
|
15.89%
|
7.32%
|
-11.21%
|
4.4%
|
6.2%
|
7.29%
|
FCF Conversion (EBITDA)
|
43.06%
|
60.04%
|
126.23%
|
58.27%
|
-
|
27.63%
|
37.89%
|
37.09%
|
FCF Conversion (Net income)
|
59.87%
|
89.04%
|
201.38%
|
114.16%
|
-
|
41.42%
|
58.68%
|
53.48%
|
Dividend per Share
2 |
23.33
|
23.33
|
27.00
|
27.00
|
30.00
|
45.29
|
56.62
|
64.08
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Fiscal Period: März |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2025 S2
|
2026 S1
|
2026 S2
|
---|
Net sales
1 |
479,573
|
502,220
|
480,168
|
265,896
|
529,965
|
281,002
|
233,933
|
-
|
280,317
|
327,480
|
607,797
|
340,479
|
330,202
|
350,835
|
375,465
|
726,300
|
446,925
|
428,431
|
-
|
391,756
|
427,900
|
745,636
|
469,950
|
486,600
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
114,454
|
40,212
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
86,163
|
52,637
|
58,465
|
38,973
|
84,742
|
39,030
|
-50,772
|
-
|
34,382
|
61,198
|
95,580
|
31,551
|
-6,551
|
44,032
|
51,068
|
95,100
|
99,488
|
17,049
|
-
|
45,002
|
57,830
|
54,820
|
73,218
|
59,300
|
-
|
-
|
-
|
Operating Margin
|
17.97%
|
10.48%
|
12.18%
|
14.66%
|
15.99%
|
13.89%
|
-21.7%
|
-
|
12.27%
|
18.69%
|
15.73%
|
9.27%
|
-1.98%
|
12.55%
|
13.6%
|
13.09%
|
22.26%
|
3.98%
|
-
|
11.49%
|
13.51%
|
7.35%
|
15.58%
|
12.19%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
87,040
|
54,124
|
66,986
|
38,893
|
85,955
|
39,931
|
-52,386
|
-
|
29,415
|
61,850
|
91,265
|
36,185
|
-596
|
52,133
|
49,967
|
102,100
|
97,749
|
37,354
|
-
|
26,694
|
-
|
54,820
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
64,426
|
64,648
|
51,667
|
27,245
|
62,465
|
31,853
|
-27,318
|
-
|
18,851
|
39,458
|
58,309
|
28,391
|
22,488
|
57,013
|
39,987
|
97,000
|
66,558
|
37,136
|
-
|
21,088
|
56,818
|
43,308
|
60,580
|
45,500
|
-
|
-
|
-
|
Net margin
|
13.43%
|
12.87%
|
10.76%
|
10.25%
|
11.79%
|
11.34%
|
-11.68%
|
-
|
6.72%
|
12.05%
|
9.59%
|
8.34%
|
6.81%
|
16.25%
|
10.65%
|
13.36%
|
14.89%
|
8.67%
|
-
|
5.38%
|
13.28%
|
5.81%
|
12.89%
|
9.35%
|
-
|
-
|
-
|
EPS
2 |
33.15
|
-
|
26.57
|
14.21
|
32.59
|
16.62
|
-10.07
|
-
|
9.840
|
20.58
|
30.42
|
14.81
|
11.73
|
29.74
|
20.85
|
50.59
|
34.72
|
19.38
|
-
|
14.43
|
24.76
|
22.60
|
30.74
|
30.28
|
-
|
-
|
-
|
Dividend per Share
2 |
11.67
|
11.67
|
13.50
|
-
|
13.50
|
-
|
-
|
13.50
|
-
|
-
|
15.00
|
-
|
-
|
-
|
20.00
|
20.00
|
-
|
25.00
|
17.00
|
-
|
30.00
|
20.00
|
-
|
30.00
|
20.00
|
25.00
|
25.00
|
Announcement Date
|
10/31/19
|
4/27/20
|
10/30/20
|
10/29/21
|
10/29/21
|
1/31/22
|
4/27/22
|
4/27/22
|
7/29/22
|
10/31/22
|
10/31/22
|
1/31/23
|
4/27/23
|
7/31/23
|
10/31/23
|
10/31/23
|
1/31/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
518,920
|
657,022
|
641,083
|
680,384
|
249,066
|
555,812
|
454,959
|
683,782
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
55,925
|
114,928
|
152,961
|
76,490
|
-143,268
|
69,530
|
108,659
|
146,320
|
ROE (net income / shareholders' equity)
|
7.8%
|
10.1%
|
5.9%
|
5.1%
|
7.8%
|
12.8%
|
12.1%
|
14%
|
ROA (Net income/ Total Assets)
|
4.31%
|
6.7%
|
3.54%
|
3.41%
|
5.36%
|
7.95%
|
6.9%
|
8.99%
|
Assets
1 |
2,168,857
|
1,926,478
|
2,147,241
|
1,962,438
|
2,035,768
|
2,525,319
|
2,685,365
|
3,043,241
|
Book Value Per Share
2 |
643.0
|
672.0
|
664.0
|
705.0
|
754.0
|
880.0
|
840.0
|
911.0
|
Cash Flow per Share
2 |
71.80
|
101.0
|
68.80
|
65.30
|
92.30
|
136.0
|
134.0
|
134.0
|
Capex
1 |
36,108
|
31,936
|
31,245
|
62,736
|
71,539
|
88,875
|
113,934
|
119,484
|
Capex / Sales
|
3.88%
|
3.25%
|
3.25%
|
6%
|
5.6%
|
5.62%
|
6.5%
|
5.95%
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/27/23
|
4/25/24
|
-
|
-
|
Last Close Price
5,010
JPY Average target price
5,673
JPY Spread / Average Target +13.24% Consensus |
1st Jan change
|
Capi.
|
---|
| +29.39% | 61.03B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|